Brief: CareMax Q3 Revenue USD 201.8 Million Vs. IBES Estimate USD 194.7 Million
09/11/2023 11:55
Nov 09 (Reuters) - CareMax Q3 adjusted EBITDA USD 2.1 million. * Q3 medical expense ratio 88% * Q3 net income USD -103.1 million
Recent news on Caremax
See all newsBrief: Bankruptcy Court Approves CareMax's $122 Mln Dip Facility
Brief: CareMax Enters Into Agreement To Sell Core Centers’ Assets
U.S. STOCKS ON THE MOVE-Henry Schein Inc, Palantir Technologies, Uber Technologies
U.S. STOCKS ON THE MOVE-Tesla Inc, Palantir Technologies and Super Micro Computer Inc
U.S. STOCKS ON THE MOVE-Silver Miners, Intellia, Robinhood